Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
Ying Gong Zhiyan Piao Siping Wu Junhao Li ZongZhong He Haixia Li Hongxia Wang Wanying Lin Xuechun Fang Ruyi Zhang Min Luo Haoran Wu Shuai Chu Chuangkun Li Yiming Peng
肿瘤学创新(英文)2025,Vol.4Issue(4):59-81,23.
肿瘤学创新(英文)2025,Vol.4Issue(4):59-81,23.DOI:10.1002/cai2.70018
Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
摘要
关键词
CAR-T therapy/checkpoint inhibitor/glioblastoma/immunotherapy/tumor microenvironmentKey words
CAR-T therapy/checkpoint inhibitor/glioblastoma/immunotherapy/tumor microenvironment引用本文复制引用
Ying Gong,Zhiyan Piao,Siping Wu,Junhao Li,ZongZhong He,Haixia Li,Hongxia Wang,Wanying Lin,Xuechun Fang,Ruyi Zhang,Min Luo,Haoran Wu,Shuai Chu,Chuangkun Li,Yiming Peng..Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions[J].肿瘤学创新(英文),2025,4(4):59-81,23.基金项目
This study was supported by the National Natural Science Foundation of China(82004105,82002218,and 82202978),President's Fund of Nanfang Hospital,Southern Medical University(2022B041 and 2024B031),and the Outstanding Youths Development Scheme of Nanfang Hospital,Southern Medical University(2024J007). (82004105,82002218,and 82202978)